BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8710788)

  • 1. [Tumor suppressor gene p53. Theoretical principles and their significance for pathology].
    Poremba C; Bankfalvi A; Dockhorn-Dworniczak B
    Pathologe; 1996 May; 17(3):181-8. PubMed ID: 8710788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the p53 gene.
    Sidransky D; Hollstein M
    Annu Rev Med; 1996; 47():285-301. PubMed ID: 8712782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The tumor suppressor gene p53 and its significance for dermatology].
    Lübbe J; Kleihues P; Burg G
    Hautarzt; 1994 Nov; 45(11):741-5. PubMed ID: 7822196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
    Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor suppressor gene p53--function and significance in gastroenterology].
    Schoppmeyer K; Keim V; Mössner J
    Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
    Preisler V; Kirchner S; Hagen R
    HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
    [No Abstract]   [Full Text] [Related]  

  • 11. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice.
    Tong WM; Lee MK; Galendo D; Wang ZQ; Sabapathy K
    Int J Cancer; 2006 Aug; 119(4):745-9. PubMed ID: 16557586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.
    Benjamin CL; Melnikova VO; Ananthaswamy HN
    Adv Exp Med Biol; 2008; 624():265-82. PubMed ID: 18348463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugging in the absence of p53.
    Aning OA; Cheok CF
    J Mol Cell Biol; 2019 Mar; 11(3):255-264. PubMed ID: 30865230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 16. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the TP53 gene in gastric and esophageal carcinogenesis.
    Bellini MF; Cadamuro AC; Succi M; Proença MA; Silva AE
    J Biomed Biotechnol; 2012; 2012():891961. PubMed ID: 22919278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.